Sandra Dovero Selected Research

Synucleins

1/2022	Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology.
1/2020	Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates.
1/2019	Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies.
12/2018	G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice.
3/2014	Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra Dovero Research Topics

Disease

20	Parkinson Disease (Parkinson's Disease) 01/2022 - 03/2003
9	Dyskinesias (Dyskinesia) 02/2014 - 01/2005
4	Parkinsonian Disorders (Parkinsonism) 01/2022 - 01/2011
3	Synucleinopathies 01/2022 - 07/2015
2	Neuroinflammatory Diseases 01/2022 - 01/2017
2	Multiple System Atrophy 01/2022 - 01/2019
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Dementia (Dementias) 01/2022
1	Gliosis 01/2022
1	Brain Diseases (Brain Disorder) 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Disease Progression 11/2010
1	Inflammation (Inflammations) 12/2009
1	Cognitive Dysfunction 02/2005
1	Substance-Related Disorders (Drug Abuse) 12/2003

Drug/Important Bio-Agent (IBA)

11	Levodopa (L Dopa)FDA LinkGeneric 08/2019 - 03/2003
6	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2016 - 12/2003
5	SynucleinsIBA 01/2022 - 03/2014
5	Dopamine (Intropin)FDA LinkGeneric 11/2012 - 01/2005
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2012
3	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 02/2014 - 08/2010
2	NeurotoxinsIBA 02/2016 - 12/2003
2	Dopamine Receptors (Dopamine Receptor)IBA 04/2010 - 01/2005
1	Phosphotransferases (Kinase)IBA 01/2022
1	Sucrose (Saccharose)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	EnzymesIBA 01/2017
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2017
1	alpha-SynucleinIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 07/2015
1	Glutamate Receptors (Glutamate Receptor)IBA 11/2012
1	Neuroprotective AgentsIBA 11/2010
1	Serotonin (5 Hydroxytryptamine)IBA 11/2010
1	Biomarkers (Surrogate Marker)IBA 11/2010
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 11/2010
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 08/2010
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2010
1	Protein Kinases (Protein Kinase)IBA 08/2010
1	AMPA Receptors (AMPA Receptor)IBA 08/2010
1	Ribosomal Protein S6IBA 08/2010
1	MicroRNAs (MicroRNA)IBA 04/2010
1	Opioid Receptors (Opioid Receptor)IBA 04/2007
1	mu Opioid Receptors (mu Opioid Receptor)IBA 04/2007
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 04/2007
1	preproenkephalinIBA 04/2007
1	Opioid Peptides (Opioid Peptide)IBA 04/2007
1	Messenger RNA (mRNA)IBA 04/2007
1	Opioid Analgesics (Opioids)IBA 04/2007
1	Deoxyglucose (2 Deoxy D glucose)IBA 02/2005
1	Guanosine 5'-O-(3-Thiotriphosphate)IBA 01/2005
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 10/2004
1	Cocaine (Cocaine HCl)IBA 12/2003

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2005
1	Injections 01/2022
1	Surgical Instruments (Clip) 01/2020
1	Deep Brain Stimulation 01/2011
1	Drug Therapy (Chemotherapy) 11/2010
1	Denervation 07/2005